Shopping Cart
Remove All
Your shopping cart is currently empty
TCMDC-135051 TFA is a highly selective and potent inhibitor of protein kinase PfCLK3.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,970 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $2,580 | 10-14 weeks | 10-14 weeks | |
| 100 mg | $3,400 | 10-14 weeks | 10-14 weeks |
| Description | TCMDC-135051 TFA is a highly selective and potent inhibitor of protein kinase PfCLK3. |
| In vitro | In a liver invasion and development assay, TCMDC-135051 TFA shows potent activity against P. berghei sporozoites in which the compound shows a pEC50 value of 6.17 (EC50=0.40 μM) . The kinase assays using recombinant PvCLK3 (P. vivax) and PbCLK3 (P. berghei) show that TCMDC-135051 TFA has near-equipotent inhibition at these two orthologs, with pIC50 values of 7.47 (IC50=0.033 μM) and 7.86 (IC50=0.013 μM), respectively. |
| Synonyms | TCMDC-135051 TFA |
| Molecular Weight | 585.61 |
| Formula | C31H34F3N3O5 |
| Smiles | O=C(O)C1=CC=C(C2=C3C(NC(C4=C(OC)C=CC(CN(CC)CC)=C4)=C3)=NC=C2)C=C1C(C)C.OC(C(F)(F)F)=O |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.